Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.9082 USD | +10.62% | -1.85% | -29.60% |
Apr. 25 | OptiNose, Inc. Provides Revenue Guidance for the First Quarter of 2024 | CI |
Apr. 25 | Transcript : OptiNose, Inc. - Special Call |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-29.60% | 92.8M | |
+33.25% | 704B | |
+28.59% | 577B | |
-3.55% | 348B | |
+18.16% | 327B | |
+4.36% | 288B | |
+14.81% | 234B | |
+4.93% | 198B | |
-9.78% | 194B | |
-3.69% | 147B |
- Stock Market
- Equities
- OPTN Stock
- News OptiNose, Inc.
- OptiNose Says US FDA Extended Review of Supplemental New Drug Application for Xhance in Chronic Rhinosinusitis